Immunoaffinity-purified interleuWn 2 (IL2) stimulated proliferation of large but not smal B cells. Stimulation was observed even when B cells were cultured at very low cell densities (3 x 104 per microwell containing 0.2 ml of medium). Addition of small numbers of purified splenic T cells did not enhance the 1L2-induced B-cell proliferative response.
These results suggest that IL2 was not operating through contaminating T cells. B cells cultured with anti-Ig antibody in vitro showed enhanced proliferation when cultured 'with ETA thymoma-derived B-cell growth factor but not when cultured with HL2. A direct role for 1L2 in B-cell activation is discussed.
Although interleukin 2 (IL2) has been shown to influence B- cell activation, it is not known whether its effect is exerted directly on the B cell or indirectly by induction of other Tcell-derived lymphokines (1-6). We and others have shown that T-cell-derived lymphokines that are enriched for IL2 activity enhance antigen-specific as well as polyclonpl B-cell activation and that this stimulatory activity is diminished when IL2 is removed by adsorption onto an IL2-dependent T-cell line (1, 3, 5) . Other investigators, however, have been unable to demonstrate a direct influence of IL2 on B-cell differentiation (7) (8) (9) or to demonstrate unequivocally specific binding of radiolabeled IL2 onto resting or activated B cells. Because of the prior unavailability of homogeneous preparations of IL2, it was uncertain whether or not the Bcell-enhancing effects of preparations enriched for IL2 could have been due to other B-cell-stimulatory lymphokines contained in these fractions. To study this more carefully, we examined the ability of immunoaffinity-purifiqd IL2 to influence B-cell activation directly. Since B-Cell Subpopulations. The enriched B-cell population was separated into five size-dependent subpopulations with a counterflow centrifuge (elutriator) as previously worked out for murine spleen cells (17) . Counterflow centrifugation opposes an outwardly directed centrifugal force with an inwardly directed force generated by the flow of fluid through the centrifuge's separation chamber. Cells of different size equilibrate at different positions in the chamber and can be removed sequentially (from smallest to largest) by increasing the rate of flow. Separation is achieved on the basis of cell size, and the effects of differences in cell density are minimal.
In these experiments, 2 x 108 purified B cells were loaded into the chamber of the counterflow centrifuge at a flow rate of 15 ml/min and a centrifuge speed of 3500 rpm (1225 x g). The flow rate then was increased to 18 ml/min and the cells were allowed to equilibrate in the chamber for 5 min. The flow rate then was increased sequentially to 22, 24, 27, 30, and 35 ml/min, and 50 ml of elutriate was collected at each flow rate (fractions 1-5, respectively; fraction 1 contained the smallest cells and fraction 5, the largest cells). All separations were performed at 4°C in phosphate-buffered saline that contained 0.35%o bovine serum albumin and 1 mM EDTA. Reproducible size separations were achieved, in which the cells in fraction 1 had a mean volume of 115.8 ± 3.7 ,um3 (mean ± SD) and the cells in each successive fraction had a progressively larger mean volume. The largest cells (fraction 5) had a mean volume of 168.0 ± 6.0 um .
Cell Culture and Proliferation. Cells were cultured at various densities in modified Mishell-Dutton medium that contained 10% endotoxin-free (<0.1 ng/ml) fetal bovine serum (HyClone, Logan, UT) and 50 ,uM 2-mercaptoethanol in flatbottomed Microtiter plates (Costar, Cambridge, MA) (0. with IL2 at 10 units/ml (Table 1) . Although IL2 stimulated a definite and reproducible increase in thymidine incorporation in unfractionated B cells, the stimulation index was usually less than 2-fold. To determine whether we could enrich for B cells responsive to IL2, we examined the responses of small (fraction 1) or large (fraction 5) B cells (Table 1) . IL2 induced a significant proliferative response in large but not small B cells. This response was evident by day 2 of the culture period (Table 2 ). Thyl.2+ cells were not detected in any of the elutriated B-cell fractions, and none of the cell fractions responded to stimulation with Con A. Nevertheless, we cannot exclude the possibility that a small number of residual T cells was responding to added IL2, particularly since large numbers of cells were cultured in these experiments. To minimize this possibility, the responses of 3 x 104 (25% the number of cells in the B-cell cultures) T cells to IL2 4,463 ± 466 Small B cells (fraction 1) were cultured at 5 x 104 per well with goat anti-mouse 8 chain antibody (GaM8, 10 pg/ml), or goat antiferritin (GaFerr, 10 pg/ml), with or without IL2 (10 units/ml) or BCGF (300 units/ml).
[VH]Thymidine (1.0 ,uCi per well) was added at 2 days, and cultures were harvested 18 hr later.
ty, it might be expected to enhance the proliferation of small B cells that have been activated to become large B cells by anti-Ig antibody. Such anti-Ig-stimulated B cells are responsive to T-cell-derived preparations of BCGF (Table 5) as has been reported by others (18) . The results indicate that IL2 did not stimulate proliferation of small B cells or of B cells activated by anti-IgM antibody. In the same experiment, BCGF derived from the EL4 thymoma line significantly enhanced the anti-IgD-induced B-cell proliferative response. Thus, if IL2 did stimulate T cells to secrete a B-cell growth factor, this B-cell growth factor differed from EL4-derived BCGF in failing to enhance anti-Ig-induced B-cell proliferation. Although it is clear that other such B-cell growth factors do exist (19) , there is no evidence for their selective production by T cells in response to IL2.
To evaluate further whether the IL2-induced B-cell proliferative response was a result of induction of a BCGF-type of activity, we examined the kinetics of the B-cell response to IL2 and to BCGF (Table 6 ). Although BCGF stimulated substantial incorporation of thymidine into large B cells, the extent was significantly less than that observed with IL2 even though the dose of BCGF used (300 units/ml) was much greater than the amount inducing optimal proliferation in the presence of anti-Ig antibody. Furthermore, wherea.; B-cell proliferation in response to IL2 was increasing at 4 days of culture, proliferation in response to BCGF had peaked by day 3, suggesting that although both IL2 and BCGF stimsulated proliferation of large B cells, their effects were exerted in different ways. To evaluate whether these lymphokines were influencing the same subpopulation of large B cells, we examined whether the proliferative response induced in large cells by EL4-derived BCGF was additive to the B-cell proliferation response induced by a suboptimal amount of IL2 ( Table 7 ). The responses were not additive, indicating that both factors stimulate proliferation of the same subset of (Table 7) , which suggests that these two factors probably do not exert their effects on different B-cell subpopulations. (iii) Substantial B-cell proliferative responses were seen as early as day 2 of culture, suggesting that IL2 does not induce proliferation of T cells, which mature (and become IL2-responsive) during the culture period. (iv) Although BCGF and IL2 appear to stimulate proliferation of the same subset of large B cells, they do so via two distinct modes of activation (Table 6 ). Whereas BCGF in nonlimiting amounts was unable to sustain a continued increase in B-cell proliferation above that seen on day 3 of culture, B-cell proliferation in response to IL2 was markedly higher by day 4 of the culture period. This suggests that IL2 is more efficient than BCGF in maintaining B cells in a proliferative state. Since no significant increase in the numbers of T cells was seen by day 4 of the culture period, the observed increase in stimulating activity of IL2 for B cells on day 4 of culture was unlikely to have been due to the induction of T-cell-derived lymphokines. This latter possibility was further excluded by the experiments summarized in Table 4 . Addition of small numbers of T cells to B-cell cultures containing IL2 produced proliferative responses not higher than those observed when B cells were cultured in the absence of T cells. For these reasons we think it most probable that IL2 exerts a direct stimulatory effect on B cells as well as an indirect one via stimulation of other T-cell-derived lymphokines when activated T cells are present in larger numbers.
We propose that resting B cells express few if any receptors for IL2, whereas activated B cells display such receptors and are directly responsive to IL2. Furthermore, the mode of activation of the B cell would determine its subsequent responsiveness to IL2: B cells activated in vitro by soluble anti-Ig will be responsive to EL4 thymoma-derived BCGF but not to IL2, but large, in vivo-activated B cells will be responsive to either signal. Such large B cells obtained from mice without further in vitro stimulation may have achieved their activated status in vivo via "cognate help" type of stimuli and this process might be critical to the generation of IL2 responsiveness. B cells activated via this linked T-cell-B-cell interaction might be exposed in vivo to a sufficient local concentration of IL2 to induce proliferation, and thus IL2 might play some role in in vivo B-cell proliferation and clonal expansion. The absence of an IL2 effect in some in vitro assays of B-cell function might therefore be due to the lack of an adequate signal for induction of IL2 responsiveness.
